The CDC's antibiotic prescribing surveillance data consistently shows that outpatient antibiotic prescribing far exceeds what clinical guidelines recommend. Their 2022 report documented approximately 236.4 million outpatient antibiotic prescriptions dispensed in the United States, with at least 30% deemed unnecessary based on diagnosis codes that do not warrant antibiotic therapy. The highest rates of inappropriate prescribing are for acute respiratory infections [1].
Francino (2016) published a comprehensive review in Frontiers in Cellular and Infection Microbiology documenting the mechanisms by which antibiotics disrupt the gut microbiota. Broad-spectrum antibiotics reduce overall bacterial load and diversity, with effects detectable within 24 hours of the first dose. The review documented that recovery trajectories vary substantially by antibiotic class, but that fluoroquinolones, clindamycin, and broad-spectrum beta-lactams cause the most severe and prolonged disruption. Some commensal species, particularly certain Bacteroides and Bifidobacterium strains, may fail to recolonize months after treatment ends [2].
Chua, Fischer, and Linder (2019) conducted a systematic review published in the Annals of Internal Medicine analyzing 52 studies of antibiotic prescribing appropriateness. Across all studies, a median of 30.4% of outpatient antibiotic prescriptions were classified as inappropriate, with rates varying by condition. For acute respiratory infections specifically, inappropriate prescribing rates exceeded 50% in multiple studies. The most commonly cited driver was prescribing antibiotics for viral diagnoses where no bacterial infection was documented [4].
The CDC's 2013 landmark report on antibiotic resistance threats cataloged 18 drug-resistant organisms by urgency level, identifying Clostridium difficile, carbapenem-resistant Enterobacteriaceae (CRE), and drug-resistant Neisseria gonorrhoeae as urgent threats. The report established the direct link between antibiotic overuse and the emergence of resistant organisms, noting that the more antibiotics are used, the more resistance develops, and that this applies to both human and agricultural antibiotic use [3].